剩余胆固醇与血糖状况的中风风险的关联:全国范围的前性队列研究

相关实验视频

Updated: Feb 28, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Fangfang Lu¹, Fan Yang¹

¹Department of Clinical Laboratory, Nanjing Jiangning Hospital, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, China.

Diabetes research and clinical practice

|February 26, 2026

概括

升高的残留胆固醇 (RC) 独立预测糖尿病前期和糖尿病患者的中风风险,特别是当LDL-C低于130 mg/dL时. 这突出了RC作为潜在的二次治疗目标.

科学领域:

心血管疾病的研究研究.
代谢综合征和糖尿病研究研究
脂质学和动脉样硬化研究研究.

背景情况:

升高的残留胆固醇 (RC) 和心血管事件之间的关联因不同的血糖状况而异.
了解这种关系对于完善风险分层和预防中风的治疗策略至关重要.

研究的目的:

研究高残留胆固醇 (RC) 在预测不同血糖状况的个体中发生中风的独立作用.
确定RC是否作为中风的额外风险标志物,特别是在糖尿病和糖尿病前期的情况下.

主要方法:

利用了来自中国健康与退休长度研究 (CHARLS) 的数据,包括年龄≥45岁且没有先前中风的参与者.
在7年内使用卡普兰-梅尔曲线,考克斯比例危险模型和受限制的立方脊柱分析,根据葡萄糖代谢和LDL-C水平分层评估发生中风风险.
将基线残留胆固醇 (RC) 分类为四分位数以进行关联分析.

主要成果:

在7年的随访期间,共有867名参与者 (9.44%) 患上中风.
在糖尿病前期 (前糖尿病) 和糖尿病 (糖尿病) 患者中,较高的RC四分位数显著增加了中风风险,但在正常葡萄糖调节 (NGR) 患者中并非如此.
高RC和中风风险之间的关联在前DM和DM个体中特别明显,LDL-C<130 mg/dL.

结论:

较高的残留胆固醇 (RC) 是糖尿病前期和糖尿病患者中发生中风的独立预测因素.
RC可能成为预防中风的有价值的额外治疗标,特别是在已经实现了LDL-C目标的患者中.
这些发现强调了在评估心血管风险时考虑RC水平的重要性,特别是在患有失糖症的风险人群中.

关键词:

糖尿病糖尿病糖尿病血糖状态血糖状态糖尿病前期的情况.剩余的胆固醇剩余的胆固醇一次性中风,中风.

更多相关视频

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

相关概念视频

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...